Runcaciguat

N/A

Report date: 2024/03/22 20:01:55

Base Information

Drug NameRuncaciguat
Drug Alias NameBAY-1101042
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSoluble guanylate cyclase stimulants
TargetsSoluble guanylate cyclase
Therapy Area/IndicationsProteinuriaKidney Failure, ChronicRenal Insufficiency, Chronic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[15] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesBayer Healthcare Company Ltd
Active IndicationsDiabetic Retinopathy
Inactive IndicationsProteinuriaKidney Failure, ChronicRenal Insufficiency, Chronic +[5] 

Other Information

ATC CodeN/A
Related LinksN/A